Related Experiment Video
Updated: Jun 2, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus
Shi-Jin Qu1, Gui-Feng Wang, Wen-Hu Duan
1Department of Natural Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China.
Abstract:
A series of tryptamine derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in the HepG2.2.15 cell line. The preliminary SAR was discussed. Compounds 2e and 4a showed potent antiviral activity (IC(50)=0.4 and <1 μM, respectively) and low cytotoxicity (CC(50)=40.6 and >25 μM, respectively).
Related Concept Videos
Antiviral Nucleoside Inhibitors
Hepatitis
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiprotozoal Agents
Inhibitors of Virion Maturation and Assembly

